JJ1017が開く核医学検査情報ネ裏準化の扉?情報統合が実現する核医学の未来?座長の言葉

摘要

A validated PET amyloid tracer could improve diagnosis and management of dementing disorders. We will report the results for the first Phase III multicenter validation study for an amyloid imaging agent, comparing cortical amyloid as evaluated by PET imaging with amyloid burden and plaque density as assessed at post mortem histology in patients with a variety of clinical diagnoses and cognitive performance levels.